Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial

Tafenoquine is a novel 8-aminoquinoline antimalarial drug recently approved by the U.S. Food and Drug Administration (FDA) for the radical cure of acute Plasmodium vivax malaria, which is the first new treatment in almost 60 years. A population pharmacokinetic (POP PK) analysis was conducted with ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Nilay, Green, Justin A., Koh, Gavin C. K. W., Duparc, Stephan, Tenero, David, Goyal, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201082/
https://www.ncbi.nlm.nih.gov/pubmed/30201820
http://dx.doi.org/10.1128/AAC.00711-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201082/
https://www.ncbi.nlm.nih.gov/pubmed/30201820
http://dx.doi.org/10.1128/AAC.00711-18

Ejemplares similares